PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34650521-5	2021	Skin fibrosis was induced in C57BL/6J (B6) and Mdr1a/b-Bcrp triple knock-out (KO) mice by daily subcutaneous injections of bleomycin (2 IU/100 microL) for 28 days.	Bleomycin	123-132	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	55-59	
25122876-6	2014	Genetic labeling of lung MSC in mice enabled determination of terminal lineage and localization of ABCG2 cells following intratracheal administration of bleomycin to elicit fibrotic lung injury.	Bleomycin	153-162	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	99-104	
34650521-11	2021	However, the skin level of MRI-1867, an MDR1 substrate, was dramatically lower in B6 mice (0.023 microM) than in Mdr1a/b-Bcrp KO mice (8.8 microM) due to a bleomycin-induced increase in efflux activity of MDR1 in fibrotic skin.	Bleomycin	156-165	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	121-125	
34650521-13	2021	MRI-1867 treatment attenuated bleomycin-induced established skin fibrosis and the associated increase in endocannabinoids in Mdr1a/b-Bcrp KO mice but not in B6 mice.	Bleomycin	30-39	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	133-137